Annox Capital LLC plans Rule 144 sale of BKNG shares

Annox Capital LLC, an entity associated with a director, has filed a notice to sell 40 common shares of BKNG under Rule 144.

Rhea-AI Filing Summary

Annox Capital LLC, an entity associated with a director, has filed a notice to sell 40 common shares of BKNG under Rule 144. The planned sale, through UBS Financial Services on Nasdaq, has an aggregate market value of 204214.44 based on the filing.

The filing also notes prior sales over the past three months by Annox Capital LLC of 40 common shares on each of 11/07/2025, 12/02/2025, and 01/02/2026, with gross proceeds of 200000.00, 200000.00, and 211615.26 respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001214607
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Booking Holdings Inc.
SEC File Number	001-36691
Address of Issuer	800 CONNECTICUT AVE NORWALK CONNECTICUT 06854
Phone	203-299-8000
Name of Person for Whose Account the Securities are To Be Sold	MYLOD ROBERT J JR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chairman

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	40	204214.44	32233815	02/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2022	Grant made to Director	Issuer			40	09/01/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Annox Capital LLC 800 Connecticut Avenue Norwalk CT 06854	Common	11/07/2025	40	200000.00
Annox Capital LLC 800 Connecticut Avenue Norwalk CT 06854	Common	12/02/2025	40	200000.00
Annox Capital LLC 800 Connecticut Avenue Norwalk CT 06854	Common	01/02/2026	40	211615.26

144: Remarks and Signature

Remarks	The shares covered by this filing are being sold by Annox Capital LLC.
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Robert J. Mylod Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)